Short Steroid Taper Tested With Tocilizumab for GCA

Results from a pilot study examining a shortened prednisone taper of 8 weeks' length rather than 26 weeks suggest it may be possible to reduce patients' duration of exposure to glucocorticoids.
Medscape Medical News

Full Story →